Resectable Pancreatic Adenocarcinoma: Is the Enhancement Pattern at Contrast-Enhanced Ultrasonography a Pre-Operative Prognostic Factor?

Ultrasound in Medicine and Biology

Volumn 35, Issue 12, 2009, Pages 1929-1937

  D'Onofrio, M ^a   Zamboni, G A ^a   Malago R ^a   Mantovani, W ^a   Principe, F ^a   Gallotti, A ^a   Faccioli, N ^a   Falconi, M ^a   Capelli, P ^a   Mucelli, R Pozzi ^a  

^a G B ROSSI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Contrast enhanced ultrasound; Mean vascular density; Pancreatic adenocarcinoma; Prognostic factor; Survival

Indexed keywords

CONTRAST ENHANCED ULTRASOUND; CONTRAST-ENHANCED ULTRASONOGRAPHY; COX PROPORTIONAL HAZARD MODEL; COX REGRESSION; KAPLAN-MEIER METHOD; MEDIAN SURVIVAL; MULTI VARIATE ANALYSIS; PANCREATIC ADENOCARCINOMA; PATIENT PROGNOSIS; POSITIVE CORRELATIONS; PROGNOSTIC FACTORS; VASCULARIZATION;

ACOUSTIC WAVES; DECISION MAKING; MULTIVARIANT ANALYSIS; PATHOLOGY; REGRESSION ANALYSIS; TUMORS; ULTRASONIC IMAGING; ULTRASONICS; ULTRASONOGRAPHY;

FLUORINE CONTAINING POLYMERS;

SONOVUE;

ADULT; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; KAPLAN MEIER METHOD; MALE; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TUMOR VASCULARIZATION;

ADENOCARCINOMA; AGED; CONTRAST MEDIA; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PREOPERATIVE CARE; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 71749099110     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2009.06.1100     Document Type: Article

References (26)

1. Alexakis N., Halloran C., Raraty M., Ghaneh P., Sutton R., and Neoptolemos J.P. Current standards of surgery for pancreatic cancer. Br J Surg 91 (2004) 1410-1427
2. D'Onofrio M., Malagò R., Zamboni G., Vasori S., Falconi M., Capelli P., and Mansueto G. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 5 (2005) 398-402
3. D'Onofrio M., Faccioli N., Malagò R., Zamboni G., and Mucelli R.P. Standardize and compare contrast-enhanced ultrasonographic digital images obtained with different technologies: How to overcome the subjectivity. J Dig Imaging 20 (2007) 256-262
4. D'Onofrio M., Megibow A.J., Faccioli N., Malagò R., Capelli P., Falconi M., and Mucelli R.P. Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. AJR Am J Roentgenol 189 (2007) 1435-1442
5. EFSUMB Study group. Guidelines and good clinical practice recommendation for the use of contrast enhanced ultrasound (CEUS)-Update 2008. Ultrashall Med 1 (2008) 28-44
6. EFSUMB Study group. Guidelines for the use of contrast agents in ultrasound. Ultrashall Med 25 (2004) 249-256
7. Galiè M., D'Onofrio M., Montani M., Amici A., Calderan L., Marzola P., Benati D., Merigo F., Marchini C., and Sbarbati A. Tumor vessel compression hinders perfusion of ultrasonographic contrast agents. Neoplasia 7 (2005) 528-536
8. Hermanek P. Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 17 (1991) 167-172
9. Kitano M., Kudo M., Maekawa K., Suetomi Y., Sakamoto H., Fukuta N., Nakaoka R., and Kawasaki T. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53 (2004) 854-859
10. Krix M., Kiessling F., Essig M., Herth F., Karcher A., Le-Huu M., Kauczor H.U., and Delorme S. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography. Invest Radiol 39 (2004) 216-222
11. Krix M. Quantification of enhancement in contrast ultrasound: A tool for monitoring of therapies in liver metastases. Eur Radiol 15 Suppl 5 (2005) E104-E108
12. Kuwahara K., Sasaki T., Kuwada Y., Murakami M., Yamasaki S., and Chayama K. Espressions of angiogenesis factors in pancreatic ductal carcinoma: A correlative study with clinicopathologic parameters and patient survival. Pancreas 26 (2003) 344-349
13. Masaki T., Ohkawa S., Amano A., Ueno M., Miyakawa K., and Tarao K. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 103 (2005) 1026-1035
14. Murphy-Lavallee J., Jang H.J., Kim T.K., Burns P.N., and Wilson S.R. Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography. J Ultrasound Med 26 (2007) 1545-1556
15. Nagase M., Furuse J., Ishii H., and Yoshino M. Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 22 (2003) 789-795
16. Numata K., Ozawa Y., Kobayashi N., Kubota T., Shimada H., Nozawa A., Nakatani Y., Sugimori K., Matsuo K., Iamada T., and Tanaka K. Contrast-enhanced sonography of pancreatic carcinoma: Correlations with pathological findings. J Gastroenterol 40 (2005) 631-640
17. Oshikawa O., Tanaka S., Ioka T., Nakaizumi A., Hamada Y., and Mitani T. Dynamic sonography of pancreatic tumors: Comparison with dynamic CT. AJR Am J Roentgenol 178 (2002) 1133-1137
18. Prokesch R.W., Chow L.C., Beaulieu C.F., Nino-Murcia M., Mindelzun R.E., Bammer R., Huang J., and Jeffrey Jr. R.B. Local staging of pancreatic carcinoma with multi-detector row CT: Use of curved planar reformations initial experience. Radiology 225 (2002) 759-765
19. Quaia E., Calliada F., Bertolotto M., Rossi S., Garioni L., Rosa L., and Pozzi-Mucelli R. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 232 (2004) 420-430
20. Schima W., Ba-Ssalamah A., Kölblinger C., Kulinna-Cosentini C., Puespoek A., and Götzinger P. Pancreatic adenocarcinoma. Eur Radiol 17 (2007) 638-649
21. Schima W., and Függer R. Evaluation of focal pancreatic masses: Comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT. Eur Radiol 12 (2002) 2998-3008
22. Seo Y., Baba H., Fukuda T., Takashima M., and Sugimachi K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 88 (2000) 2239-2245
23. Solbiati L., Tonolini M., Cova L., and Goldberg S.N. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11 Suppl 3 (2001) E15-E26
24. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T., Horiuchi T., and Iki M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 56 (1996) 2671-2676
25. Tran K.T., Smeenk H.G., van Eijck C.H., Kazemier G., Hop W.C., Greve J.W., Terpstra O.T., Zijlstra J.A., Klinkert P., and Jeekel H. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: A prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240 (2004) 738-745
26. Yeo C.J., Cameron J.L., Lillemoe K.D., Sitzmann J.V., Hruban R.H., Goodman S.N., Dooley W.C., Coleman J., and Pitt H.A. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 (1995) 721-731 discussion 731-733